ak 295 has been researched along with Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, AL; Bahr, BA; Blomgren, K; Hagberg, H; Hallin, U; Kawashima, S; McRae, A; Puka-Sundvall, M; Saido, TC | 1 |
| Bahr, BA; Blomgren, K; Hagberg, H; Karlsson, JO; Leverin, AL; Mallard, C; Wang, X; Zhu, C | 1 |
2 other study(ies) available for ak 295 and Hypoxia
| Article | Year |
|---|---|
Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia.
Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Calcium-Binding Proteins; Calpain; Cell Membrane; Cysteine Proteinase Inhibitors; Dipeptides; Enzyme Activation; Female; Functional Laterality; Hypoxia; Male; Rats; Rats, Wistar; Up-Regulation | 1999 |
Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"?
Topics: Animals; Animals, Newborn; Apoptosis; Brain; Calpain; Carrier Proteins; Caspase 3; Caspases; Cysteine Proteinase Inhibitors; Dipeptides; Enzyme Activation; Enzyme Precursors; Female; Humans; Hypoxia; Immunoblotting; Immunohistochemistry; Inhibitory Concentration 50; Ischemia; Male; Microfilament Proteins; Protease Inhibitors; Rats; Rats, Wistar; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substrate Specificity; Time Factors | 2001 |